Human Medicines European Public Assessment Report (EPAR): DuoResp Spiromax, Budesonide / Formoterol, Pulmonary Disease, Chronic Obstructive,Asthma, Date of Authorisation: 28/04/2014, Revision: 7, Status: Authorised

Case Medical Research
doi 10.31525/cmr-12043e0
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Case Journals

Related search

Human Medicines European Public Assessment Report (EPAR): Brimica Genuair, Aclidinium / Formoterol Fumarate Dihydrate, Pulmonary Disease, Chronic Obstructive, Date of Authorisation: 19/11/2014, Revision: 11, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Pregabalin Pfizer, Pregabalin, Anxiety Disorders,Epilepsy, Date of Authorisation: 10/04/2014, Revision: 13, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): PritorPlus, Telmisartan / Hydrochlorothiazide, Hypertension, Date of Authorisation: 22/04/2002, Revision: 33, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Bronchitol, Mannitol, Cystic Fibrosis, Date of Authorisation: 13/04/2012, Revision: 13, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Revinty Ellipta, Fluticasone Furoate / Vilanterol, Asthma, Date of Authorisation: 02/05/2014, Revision: 16, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Farydak, Panobinostat, Multiple Myeloma, Date of Authorisation: 28/08/2015, Revision: 6, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Intelence, Etravirine, HIV Infections, Date of Authorisation: 28/08/2008, Revision: 23, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Lenvima, Lenvatinib, Thyroid Neoplasms, Date of Authorisation: 28/05/2015, Revision: 6, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Raloxifene Teva, Raloxifene, Osteoporosis, Postmenopausal, Date of Authorisation: 29/04/2010, Revision: 8, Status: Authorised

Case Medical Research
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy